S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
Log in

ESSA Pharma Stock Forecast, Price & News

+0.87 (+5.43 %)
(As of 01/19/2021 12:00 AM ET)
Today's Range
Now: $16.88
50-Day Range
MA: $10.27
52-Week Range
Now: $16.88
Volume449,450 shs
Average Volume372,568 shs
Market Capitalization$541.24 million
P/E RatioN/A
Dividend YieldN/A
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.
ESSA Pharma logo


Overall MarketRank

1.09 out of 5 stars

Analyst Opinion: 1.5Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:EPIX



Sales & Book Value

Annual SalesN/A
Book Value$2.47 per share


Net Income$-23,440,000.00


Market Cap$541.24 million
Next Earnings Date2/11/2021 (Estimated)
OptionableNot Optionable
+0.87 (+5.43 %)
(As of 01/19/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EPIX News and Ratings via Email

Sign-up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

ESSA Pharma (NASDAQ:EPIX) Frequently Asked Questions

How has ESSA Pharma's stock been impacted by COVID-19 (Coronavirus)?

ESSA Pharma's stock was trading at $4.07 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, EPIX stock has increased by 314.7% and is now trading at $16.88.
View which stocks have been most impacted by COVID-19

Is ESSA Pharma a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ESSA Pharma in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ESSA Pharma stock.
View analyst ratings for ESSA Pharma
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than ESSA Pharma?

Wall Street analysts have given ESSA Pharma a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but ESSA Pharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is ESSA Pharma's next earnings date?

ESSA Pharma is scheduled to release its next quarterly earnings announcement on Thursday, February 11th 2021.
View our earnings forecast for ESSA Pharma

How were ESSA Pharma's earnings last quarter?

ESSA Pharma Inc. (NASDAQ:EPIX) announced its quarterly earnings data on Tuesday, December, 15th. The company reported ($0.17) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.20) by $0.03.
View ESSA Pharma's earnings history

What price target have analysts set for EPIX?

4 equities research analysts have issued 12 month price objectives for ESSA Pharma's shares. Their forecasts range from $9.00 to $20.00. On average, they expect ESSA Pharma's stock price to reach $15.75 in the next twelve months. This suggests that the stock has a possible downside of 6.7%.
View analysts' price targets for ESSA Pharma
or view Wall Street analyst' top-rated stocks.

Are investors shorting ESSA Pharma?

ESSA Pharma saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 15,200 shares, an increase of 149.2% from the December 15th total of 6,100 shares. Based on an average daily volume of 126,100 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.1% of the company's stock are sold short.
View ESSA Pharma's Short Interest

Who are some of ESSA Pharma's key competitors?

What other stocks do shareholders of ESSA Pharma own?

Who are ESSA Pharma's key executives?

ESSA Pharma's management team includes the following people:
  • Dr. David Ross Parkinson, Pres, CEO & Director (Age 71, Pay $626.81k)
  • Mr. David S. Wood C.M.A., CPA, M.B.A., MBA, CPA, CMA, Chief Financial Officer (Age 64, Pay $311.52k)
  • Mr. Peter A. Virsik M.B.A., M.S., Exec. VP & COO (Age 50, Pay $544.66k)
  • Dr. Alessandra Cesano, Chief Medical Officer
  • Chandtip Chandhasin, Exec.
  • Erica Osbourne, Exec.
  • Erin Rudsinski, Exec.
  • Leah Dimascio, Exec.
  • Loleta Harris, Exec.
  • Neil Thapar, Exec.

What is ESSA Pharma's stock symbol?

ESSA Pharma trades on the NASDAQ under the ticker symbol "EPIX."

Who are ESSA Pharma's major shareholders?

ESSA Pharma's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Rhenman & Partners Asset Management AB (0.49%).

Which major investors are buying ESSA Pharma stock?

EPIX stock was bought by a variety of institutional investors in the last quarter, including Rhenman & Partners Asset Management AB.

How do I buy shares of ESSA Pharma?

Shares of EPIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ESSA Pharma's stock price today?

One share of EPIX stock can currently be purchased for approximately $16.88.

How big of a company is ESSA Pharma?

ESSA Pharma has a market capitalization of $541.24 million. The company earns $-23,440,000.00 in net income (profit) each year or ($1.04) on an earnings per share basis. ESSA Pharma employs 25 workers across the globe.

What is ESSA Pharma's official website?

The official website for ESSA Pharma is www.essapharma.com.

How can I contact ESSA Pharma?

ESSA Pharma's mailing address is 999 WEST BROADWAY SUITE 720, VANCOUVER A1, V5Z 1K5. The company can be reached via phone at 778-331-0962 or via email at [email protected]

This page was last updated on 1/20/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.